Skip to main content
Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
33.23
-0.43 (-1.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Celldex Therapeutics Revenue

In the year 2025, Celldex Therapeutics had annual revenue of $1.55M, down -77.99%. Celldex Therapeutics had revenue of $121.00K in the quarter ending December 31, 2025, a decrease of -89.70%.

Revenue (ttm)
$1.55M
Revenue Growth
-77.99%
P/S Ratio
1,687.59
Revenue / Employee
$7,803
Employees
198
Market Cap
2.61B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.55M-5.48M-77.99%
Dec 31, 20247.02M137.00K1.99%
Dec 31, 20236.88M4.53M192.02%
Dec 31, 20222.36M-2.29M-49.32%
Dec 31, 20214.65M-2.77M-37.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ADMA Biologics 510.17M
Zai Lab 460.16M
Tarsus Pharmaceuticals 451.36M
IDEAYA Biosciences 218.71M
Soleno Therapeutics 190.41M
Beam Therapeutics 139.74M
Immunome 6.94M
Revenue Rankings

CLDX News

More News